Condition: Lung Neoplasms · Sponsor: Rutgers, The State University of New Jersey
Hypothesis 1a: The investigators anticipate that navigator decision coaching, compared to enhanced usual care (EUC) will result in higher quality SDM for lung cancer screening (LCS )(primary outcome), greater knowledge of lung cancer screening benefits and harms, and lower decisional conflict. Hypothesis 1b: Compared to enhanced usual care (EUC), we expect that TELESCOPE will result in more screening discussions, increased initial for lung cancer screening (LCS) with low-dose CT scan (LDCT) uptake among interested participants, increased adherence to repeat LCS and diagnostic testing, and increased smoking cessation referrals for current smokers. Hypothesis 2: The investigators expect that a "booster" coaching session will increase adherence to repeat lung cancer screening (LCS).
This description comes directly from the study's public registry record.
Julie E Chapman-Greene, PhD, MPH · 732-865-3375 · chapmaje@cinj.rutgers.edu
Rebecca Ayala · 732-258-6982 · raa191@cinj.rutgers.edu
Always discuss trial participation with your own doctor first.
| Rutgers Cancer Institute | New Brunswick, New Jersey, United States | Recruiting |
| The University of Texas MD Anderson Cancer Center | Houston, Texas, United States | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05491213